Dexamethasone effect on the duration of interescalenic brachial plexus block guided by ultrasound for videoarthroscopic shoulder surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

REBEC

Registry ID

RBR-86mhm2

Enrollment

Unknown

Registered

2016-04-05

Start date

2015-12-03

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff syndrome. Shoulder joint. Elective Surgical Procedures

Interventions

Use of dexamethasone in brachial plexus block guided by ultrasound to prolong the analgesia time and reduce incidence of postoperative nausea and vomiting. Patients will be randomly assign to the cont

Drug

D04.808.745.432.769.344

Eligibility

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: patients submitted to videoarthroscopy shoulder surgery

Exclusion criteria

Exclusion criteria: patients under 18 years old, previous history of allergy to any used medication in the procedure and diabetes (because of potential hyperglicemia)

Design outcomes

Primary

Measure	Time frame
The time duration will be analyzed sensory and motor block, Visual Analogic Scale of pain, as well as the presence of nausea or vomiting in the first 48 hours after surgery. It is expected, as shown in other studies , that dexamethasone prolongs the blocking time , improve the referred pain and reduce the incidence of postoperative nausea and vomiting .	—

Secondary

Measure	Time frame
the use of rescue medications, the presence of nausea or vomiting in the first 48 hours after surgery.	—

Countries

Brazil

Contacts

Public ContactPatricia Marchioro

Sianest

patty_smb@hotmail.com+55(48)91578525

Outcome results

None listed

Source: REBEC (via WHO ICTRP)